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Background: Risk stratification in DCM patients with advanced CHF remains a major clinical challenge. A simple manner to non-invasively and 
reliably risk stratify this cohort would have obvious advantages. Utilizing CMR, via DHE, we hypothesize that the presence of +mid-wall myocardial 
stripe will represent an adverse prognosis in primary dilated cardiomyopathy (CM), thus providing a reliable tool for risk stratification; in contrast to 
our current ‘watch and wait’ approach.
Methods: Over 39 consecutive months, 51 potential cardiomyopathy pts were referred for standard 3D CMR (1.5T GE, Milwaukee, WI) to 
interrogate the LV pattern, distribution and extent of DHE (MultiHance, Princeton, NJ). Of these, 21 pts had a pure DCM and met the inclusion 
criteria for this trial. DCM pts were categorized binarily into: 1) +midwall myocardial Stripe 2)_midwall Stripe groups, based on CMR images. All pts 
received guideline based optimal medical therapy. Major adverse clinical events (MACE), mortality, need for LV assist device (LVAD), and need for 
urgent cardiac transplantation (Tx), were evaluated over the next 6 months.
Results: There were no differences between groups for demographics, baseline LVEF, LV, LVEDD), NYHA class or hemodynamics. All pts were alive at 
6 months while 11/21 (52%) were in the +stripe group. The group with +Stripe categorization on CMR strongly predicted the need for LVAD and/or 
urgent/late Tx surgery over ensuing 6 months (X2=10; p <0.005 and by Kaplan Meier plots). Specifically, 7/11 (74%) +Stripe pts required urgent Tx 
by 6 months (5/7 pts within 5 weeks). The median time from CMR to Tx/LVAD was 2±0.5 wks. Importantly, zero pts in the _Stripe group experienced 
need for LVAD or Tx. Similarly, +Stripe strongly predicted MACE (p<0.005), while zero pts in the _Stripe group had MACE.
Conclusion: These preliminary data suggest that the presence of +stripe on CMR is remarkably predictive of LVAD and Tx need over the ensuing 6 
months in DCM pts while a _stripe has 100% negative predictive power for such. Incorporating a CMR ‘pattern driven prognosis’ into routine practice 
may help identify these high risk DCM pts. Moreover, CMR may help conservatively manage low risk pts while expectantly manage high-risk pts.
